On the other hand, the enhanced promoter activity of the CTLA4 T allele could increase CTLA4 mRNA levels and the expression of CTLA4 protein in T-cells affecting proliferation and activation, mitigating the anti-tumoral immune response, and promoting tumoral immune surveillance escape, thus conferring an increased risk of CRC. This evidence concerns the gene CTLA4 and colorectal carcinoma.